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Phospholipid bilayerRTA3 is an α-helical, amphipathic peptide with broad-spectrum activity against Gram-negative bacteria and
low mammalian cell toxicity. RTA3 contains a cysteine residue, replacement of which with an alanine or
serine (RTA3-C15S) virtually abolishes antimicrobial activity. Much of the activity of RTA3 can be recovered
in RTA3-C15L, indicating that the C15 residue functions largely as a bulky hydrophobic side chain promoting
target cell membrane interactions. The poorly active RTA3-C15S is a useful variant for assessing the
mechanistic aspects of RTA3 activity. Binding and membrane perturbation in vesicles containing different
proportions of negative surface charge are analyzed in terms of amino acid-speciﬁc free energy contributions
to interfacial binding, which likely underlie variations in antimicrobial activity amongst RTA3 variants.
Comparison with published free energy scales indicates that the reduced electrostatic contribution to
binding to membranes having reduced negative surface charge can be compensated in RTA3 (but not RTA3-
C15S) by a slightly deeper insertion of the C-terminus of the peptide to maximize hydrophobic contributions
to binding. Analysis of inner membrane (IM)- and outer membrane (OM)-selective permeabilization of
Escherichia coli demonstrates a broad similarity between peptide effects on vesicles with low negative
surface charge (20% negatively charged lipids), E. coli membrane perturbation, and antimicrobial activity,
supporting a role for membrane perturbation in the killing mechanism of RTA3. The results demonstrate that
large variations in antimicrobial activity on subtle changes in amino acid sequence in helical amphipathic
peptides can be rationalized in terms of the thermodynamics of peptide binding to membranes, allowing a
more systematic understanding of antimicrobial activity in these peptides.NaCl, pH 7.4; CD, circular
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The antimicrobial peptide RTA3, an optimized version of a
commensal-derived peptide, has strong anti-Gram-negative activity
combinedwith lowmammalian cell toxicity [1]. RTA3 is a C-terminally
amidated 16 residue peptide rich in basic amino acids (Arg and Lys;
see amino acid sequence in Table 1) and conforms to the positively
charged amphipathic helical motif of a large class of antimicrobialpeptides [2]. These peptides are widely distributed in nature and have
been isolated from a variety of sources including mammalian tissues,
amphibia, insects, bacteria, andplants [2–6]. Amphipathic peptides are
bactericidal and fast acting compared to conventional antibiotics, with
a broad spectrum of activities against targets such as bacteria, fungi,
viruses, and tumour cell lines. Therapeutic potential in these peptides
resides in selective killing of target bacteria over normal mammalian
cells, with this selectivity arising largely from the minimal negative
surface charge in the external bilayer leaﬂet of mammalian cells,
compared with the high content of negatively charged lipids in
bacterial cellmembraneswhich greatly promotes binding of positively
charged peptides [7,8].
We recently showed that the low mammalian cell toxicity of RTA3
results from disruption of the nonpolar helix face of the peptide with
an arginine (R5) residue which abolishes binding to neutral mem-
branes such as those of mammalian cells [1]. The positive charge is
accommodated in negatively charged membranes, possibly by tilting
of the peptide helix at the membrane interface to allow the arginine
side chain to access the well-solvated polar regions of the membrane.
RTA3 also contains a cysteine residue, replacement of which in an
Table 1
Biological activities of peptides.
MIC
P. aeruginosa E. coli E. coli E. coli
ATCC 27853 ATCC 25922 UB 122 345-2
µM µM µM µM
RTA3a 4 2 4 4
RTA3-C15S 275 138 138 69
RTA3-C15A 277 139 138 70
RTA3-C15L 17 8 4 4
Polymyxin E 2 1 0.5 0.5
a RTA3 amino acid sequence is: RPAFRKAAFRVMRACV-NH2.
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Cysteine residues have a variety of roles in antimicrobial peptides. In
some cases, such as mammalian cryptidins [9], or tree frog distinctins
[10], cysteine residues are involved in homo- or heterodimerization.
Some antimicrobial peptides have internal disulﬁde bonds [11]. In
other cases (e.g., maximins from frog skin [12]), antimicrobial activity
requires a free cysteine thiol. The latter observationmay suggest a role
for a free cysteine residue in receptor-mediated heterodisulphide
interactions or perhaps in metal ion binding.
Here, we assess the mechanism of action of RTA3, focussing on the
role of the C15 residue. In the ﬁrst part of the paper, we characterise
the relationship between membrane-speciﬁc perturbation and anti-
microbial activity and show that peptide binding to membranes and
membrane perturbation can be understood in terms of free energy
contributions to the partitioning of helical peptides into membranes.
In the second part, we characterise Escherichia coli inner and outer
membrane-speciﬁc perturbation by the peptides and assess their
relationships to bacterial killing. We ﬁnd that a Cys15 to Ser15 variant
(RTA3-C15S) is useful in addressing mechanistic aspects of the
peptide. The data demonstrate that rather subtle structural changes
in RTA3 peptides can have large effects on antimicrobial activity and
that these can be understood in terms of the thermodynamics of
membrane interactions.
2. Materials and methods
2.1. Peptide synthesis, puriﬁcation, and characterization
The peptides listed in Table 1 were synthesised by Dr. G.
Bloomberg of the Bristol Centre for Molecular Recognition using
standard Fmoc solid-phase synthesis. The peptides were puriﬁed by
HPLC and were conﬁrmed to be at least 97% pure by analytical HPLC
and to have the predicted m/e ratio by mass spectrometry.
Phospholipids, produced from egg yolk, were from Lipid Products
(Nutﬁeld, UK), carboxyﬂuorescein (CF) was from Sigma (Poole, UK),
and ﬂuorescein–phosphatidylethanolamine (FPE) was from Avanti
(Alabaster, AL, USA).
2.2. Biological activities
Minimum inhibitory concentrations (MIC) of the peptides were
determined by broth microdilution according to the Clinical and
Laboratory Standards Institute [13]. About 90 µL of 0.5–1×106 CFU/
mL of Pseudomonas aeruginosa ATCC 27853 and E. coli ATCC 25922 in
Mueller Hinton media (plus cations) broth (BD, Baltimore, MD, USA)
was incubated in 96-well microtitre plates with serial twofold
dilutions of the peptides. Minimum inhibitory concentrations
(MICs) were deﬁned as the lowest peptide concentration with no
visible growth of bacteria after 24 hours at 37 °C. All measurements
were made in triplicate and averaged.2.3. Preparation of lipid vesicles
All experiments were performed at room temperature. Large
unilamellar vesicles (100 nm in diameter) were used for all spectro-
scopic measurements except for circular dichroism (CD) spectroscopy
for which smaller (50 nm) vesicles were used to minimize light
scattering effects. Lipidswere dried fromchloroform/methanol solution
and pumped under high vacuum to remove traces of solvent. Dried
lipids were hydrated at a concentration of 10 mg/mL in 10 mM Tris–
HCl, pH7.4 containing either 107 mMNaCl (bufferA), or, for theCF-dye-
release experiments, 50 mMCF. Vesicles dopedwith FPEwere prepared
similarly except that 0.5 mol.% of FPE in methanol was added to the
lipids in organic solvent before drying. Hydrated lipids were freeze-
thawed 3 times and extruded 10 times through two 100-nm or 50-nm
pore membranes using a Lipex Biomolecular extruder (Vancouver,
Canada). Vesicles for peptide binding, monitored using either trypto-
phan ﬂuorescence or FPE ﬂuorescence, were used directly. Vesicles for
CF-dye-release measurements were used after gel ﬁltration on a
Sephadex G-15 column with buffer A as the mobile phase to remove
nontrapped CF. Thus, in all experiments, interaction of the peptidewith
vesicles was determined in the same buffer (buffer A).
2.4. Fluorescence and circular dichroism spectroscopy
Fluorescence measurements were made using a SPEX Fluoromax
ﬂuorimeter (Horiba Jobin Yvon, Longjumeau, France). Peptide solu-
tions were made in plastic tubes or cuvettes to minimize loss of
peptide at low concentrations due to binding to glass surfaces. For the
measurement of vesicle-induced changes in the emission spectra of
tryptophan in Trp-containing peptides, a 2-µM peptide solution was
incubated in buffer A, and aliquots of vesicles suspension were added
to give total lipid concentrations in the range 0 to 300 µM total lipid.
Tryptophan ﬂuorescence was excited at 280 nm, and the emission
spectrumwasmeasured between300 and450 nm in 1-nm increments
with 1-s signal averaging.Weused the lipid-induced spectral blue shift
(Δλ, corresponding to the change inwavelength of the emission signal
maximum compared to the lipid-free spectrum) to monitor peptide
binding and determined using a solution of 2 μM tryptophan in buffer
A that light scattering artifacts [14] were insigniﬁcant at the lipid
concentrations required to sample the binding curves. The value of Δλ
was plotted against the lipid concentration and ﬁtted to a simple
hyperbolic function (Eq. (1)) to obtain estimates of the maximum
ﬂuorescence emission blue shift (Δλmax) and an apparent binding
constant that is equivalent to the concentration of lipid at which the
lipid-induced blue shift was half-maximal (KL).
Δλ = Δλmax lipid½ = KL + lipid½ ð Þ ð1Þ
An equivalent analysis was made for the FPE binding data. In this
case, a vesicle sample in buffer A containing lipid at a total concen-
tration of 65 μM was titrated with aliquots of peptide in the range 0–
40 μM while monitoring the ﬂuorescence emission at 520 nm
resulting from excitation of FPE electronic transitions at 490 nm.
Addition of positive charge to the peptide surface upon peptide
binding results in an enhancement of the FPE ﬂuorescence, ΔF [15]. In
these analyses, ΔF (ﬂuorescence intensity minus the peptide-free
ﬂuorescence intensity) was plotted against the peptide concentration
and ﬁtted to Eq. (2) to obtain estimates of the maximum ﬂuorescence
enhancement (ΔFmax) and KP, the apparent binding constant,
equivalent in this case to the peptide concentration at which the
peptide-induced ﬂuorescence enhancement was half-maximal.
ΔF = ΔFmax peptide½  = KP + peptide½ ð Þ ð2Þ
We note that KL and KP are not equivalent (i.e., the FPE and Trp
ﬂuorescence data cannot be ﬁtted to a single equilibrium binding
1 A. Hawrani, C. E. Dempsey, R. A. Howe, and T. R. Walsh, presented at the 47th
ICAAC meeting, Chicago, September 2007.
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partitioning rather than a discrete site-binding phenomenon, as
described in more detail elsewhere [1]. However, each of these can be
used to determine a free energy change for membrane binding, δΔG,
that results from changing the peptide sequence, according to Eq. (3),
where the subscripts refer to the K values for peptides 1 (e.g., wild
type) and 2 (single amino acid substitution), determined either from
lipid FPE ﬂuorescence (KP) or peptide Trp ﬂuorescence (KL).
δΔG = −RT ln KP1 = KP2ð Þ; δΔG = −RTln KL1 = KL2ð Þ ð3Þ
Peptide-induced dye release from vesicles loaded with CF was
measured from the loss of CF self-quenching as the dye dilutes into
the extravesicular medium. Experiments were done with the same
lipid concentration (65 µM) as the FPE binding measurements and in
buffer A so that data from the different experiments can be
interpreted in a consistent manner. CF emission was measured at
520 nm (excitation at 490 nm). The ﬂuorescence resulting from 100%
release of encapsulated CF was determined by adding 10 µL of 20%
Triton X-100. To ensure rapid mixing of peptide and vesicles and to
avoid high local concentrations of peptide, 1 mL of a peptide solution
at double the post-mix concentration was rapidly ejected from an
Eppendorf pipette into 1 mL of a vesicle suspension at 130-µM
concentration (65 µM post-mix) to initiate binding and dye release.
The ﬂuorescence emission intensity was measured 3 min after mixing
CF-loaded vesicles with peptide. The dye release data were ﬁtted to an
equation deﬁning a sigmoidal dependence on peptide concentration,
yielding the n values listed in brackets in Table 2, where f is the
fraction of total dye released, fmax is the maximum value of f, and K is a
constant.
f = fmax peptide½ n = K + peptide½ n
  ð4Þ
Circular dichroism (CD) spectra were measured at 20 °C using a
Jobin-Yvon CD6 spectropolarimeter (Horiba Jobin Yvon, Longjumeau,
France). All samples were made in buffer A. Vesicles for CD
spectroscopy were extruded through 50-nm pore diameter ﬁlters to
minimize the effects of light scattering, and spectra were measured in
0.1-mm path length cuvettes to further minimize scattering con-
tributions. Spectra are averages of 9 scans with the appropriate
peptide-free blank spectra subtracted and were zeroed at 260 nm
before plotting without smoothing.
2.5. Outer membrane permeability
Outer and inner membrane permeabilities were determined as
described previously [16]. E. coli cells overexpressing β-lactamase
were grown to logarithmic phase,washed, and resuspended (108 CFU/
mL) in 10 mM HEPES buffer pH 7.4. About 90 µL of 1×107 CFU of the
test organism (E. coli 345-2) containing 20 µg/mL nitroceﬁn was then
added to 96-well microtitre plates containing serial twofold dilutions
of antimicrobial peptides. Nitroceﬁn cleavage was monitored by mea-
suring A490. All data were measured in triplicate.
2.6. Inner membrane permeability
Inner membrane permeability was determined by measuring the
β-galactosidase activity of lactose permease-deﬁcient E. coli at 30 °C
using ONPG as substrate. E. coli cells overexpressing the β-
galactosidase enzyme (E. coli 122) were grown to logarithmic phase,
washed, and resuspended (108 CFU/mL) in phosphate buffered saline
pH 7.4. About 90 µL of 1×107 CFU of the test organism containing
0.4 mg/mL ONPG was then added to 96-well microtitre plates
containing serial twofold dilutions of antimicrobial peptides. The
production of o-nitrophenol was monitored spectrophotometricallyat 420 nm. An equivalent volume of water replaced the peptide
solution in the control assay. All data were measured in triplicate.
2.7. Peptide-induced bacterial lethality
MICmicrotitre plates were set up as described before, and residual
live bacteria following incubation at each peptide concentration were
determined by plating aliquots ontoMueller Hinton agar plates. Plates
were incubated at 37 °C, and the colony-forming units (CFUs) were
counted after 24 hours. Peptide-induced lethality is expressed as a
percentage of complete lethality, 100% indicating complete killing (no
detectable colonies). All data were measured in triplicate.
3. Results
3.1. Role of the cysteine-15 residue in antimicrobial activity of RTA3
Each of the potential peptides in the Streptococcus mitis genetic
element encoding RTA peptides has a Cys-15 residue1 (see amino acid
sequence of RTA3 in Table 1), and preliminary (alanine scan)
mutagenesis showed that replacement of Cys-15 with alanine greatly
reduces antimicrobial activity (Table 1). These observations suggest a
role for the C15 residue in high antimicrobial activity of RTA peptides.
To test the possibility that the C15 residue is involved in homo-
dimerization, we attempted air oxidation of RTA3 using conditions
that readily produce high disulﬁde yields in related Cys-containing
antimicrobial peptides [17,18]. Surprisingly, no dimerization could be
detected using mass spectrometry. The inability to homodimerize
RTA3 (and the “wild-type” RTA1) is not due to structure formation in
solution, since RTA peptides are unstructured at concentrations used
for dimerization by air oxidation [1]. Indeed, chemical preactivation of
RTA3 cysteine-thiols during synthesis was also unsuccessful in
producing detectable dimerized peptide (Dr. G. Bloomberg, personal
communication). We conclude that the sequence of bulky hydropho-
bic side chains in the C-terminus of the peptide precludes productive
interactions of cysteine thiols on adjacent peptides. In addition, the
antimicrobial activity of RTA3was unaffected by the presence of 50 μM
dithiothreitol (DTT) when tested against Gram-negative bacteria that
are tolerant to DTT at this concentration (not shown). These
observations support the conclusion that RTA3 is active as its free
thiol form.
These observations do not rule out the possibility that hetero-
disulﬁde formation involving the RTA3 C15 thiol and a thiol group in a
protein in the target bacteria are important for activity, nor the
possibility that ion chelation might have some role in antimicrobial
activity, although the lack of effect of DTT on RTA3 activity does not
support these interpretations. To explore the role of the C15 residue
further, we prepared additional substitution variants, RTA3-C15S and
RTA3-C15L, to investigate whether the C15 thiol could be replaced
either with a hydroxyl group (serine) or with a residue sharing high
hydrophobicity with cysteine (leucine). The antimicrobial activity of
RTA3 was not recovered in the C15S mutant, but high activity was
recovered in the RTA3-C15L replacement analogue, indicating that a
dominant role of the C15 residue is to provide a bulky nonpolar side
chain on the nonpolar face of the amphipathic helix (Table 1).
3.2. Peptide-induced membrane perturbation of vesicles containing
trapped carboxyﬂuorescein
Previously, we showed that the ability of RTA3 peptides to bind at
the surface of negatively charged phospholipid bilayer vesicles com-
posed of 50% egg phosphatidylcholine (PC) and 50% egg phosphati-
dylglycerol (PG) and induce the release of trapped ﬂuorescent dyes
Fig. 1. Peptide-induced CF release from 100 nm PE/PG/CL (80:10:15) LUV in buffer A.
Peptides are (●) RTA3, (o) RTA3-C15L, (▲) RTA3-C15S. The total lipid concentration
was 65 μM.
Fig. 2. Peptide-induced CF release from 100 nm PC/PG LUV in buffer A, as a function of
PG content. The total lipid concentration was 65 μM. Panels A, B, and C are data for
RTA3, RTA3-C15L, and RTA3-C15S, respectively. Lipid mixtures are (●) PC/PG (50:50),
(o) PC/PG (80:20), (▲) PC/PG (90:10), (Δ) PC (100%).
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bacteria [1]. In the case of RTA3-C15S this correlation breaks down, so
that while dye release from negatively charged membranes (PC/PG,
50:50) is reduced somewhat in RTA3-C15S compared to RTA3, the
reduction is small (around 3-fold; see Fig. 2). However, when these
experiments are repeated using a lipid composition more character-
istic of Gram-negative bacterial membranes (PE/PG/CL, 80:10:15),
RTA3-C15S becomes much less active (by around 15- to 20-fold)
relative to RTA3 or RTA3-C15L (Fig. 1).
This observation may be interpreted in two ways. Either a speciﬁc
property of the more complex membrane suppresses the ability of
RTA3-C15S to bind and disrupt the membrane or this variant requires
a high negative charge density to compensate for a reduction in
amphipathic moment when a nonpolar amino acid (Cys or Leu) is
replaced by a polar amino acid (Ser) on the nonpolar face of the
amphipathic helix [19]. We tested this by measuring the relative
membrane-perturbing activity of the peptides in a PC/PG mix in
which the PG content was reduced from 50% to 20% or 10%. These data
are shown in Fig. 2. RTA3-C15S is nearly as active as RTA3 and RTA3-
C15L in permeabilizing membranes composed of 50% PG in PC, but
when the negative membrane surface charge is suppressed by
reducing the PG content to 20% (PC/PG, 80:20), RTA3-C15S is
virtually inactive as a membrane permeabilizer (Fig. 2C). Both RTA3
and RTA3-C15L retain very strong membrane permeabilizing activity
in mixed PC/PG bilayers containing only 20% PG (Figs. 2A and B). Only
in 10% PG are the permeabilizing activities of RTA3 and RTA3-C15LFig. 3. Binding of RTA3 peptides to PG/PC (50:50) (circles) and PG/PC (20:80)
(squares). Panel A is RTA3 (ﬁlled symbols) and RTA3-C15S (open symbols) binding to
100 nm vesicles doped with 0.5% FPE in buffer A. The total lipid concentration was
65 μM. Dotted lines are ﬁts to Eq. (2). Panel B is binding of RTA3-F9W (ﬁlled symbols)
and RTA3-F9W,C15S (open circles) binding to undoped lipids in buffer A. Dotted lines
in panel B are ﬁts to Eq. (1).
Fig. 4. Circular dichroism spectra of RTA3 (●) and RTA3-C15S (o) in 50-nm diameter
PC/PG (50:50) vesicles. Peptide and total vesicular lipid concentrations were 150 μM
and 10 mM, respectively, in buffer A, and spectra were measured in 0.1-mm path length
cuvettes at 20 °C.
Table 2
Effects of Cys15-Ser substitution on membrane interactions of RTA3.
Binding CF dye-releasea
50% PG 20% PG 50% PG 20% PG
FPE ﬂuorescenceb μM μM
μM μM
RTA3 1.2 1.5 0.09 (2.3c) 0.40 (1.7)
RTA3-C15S 1.6 18 0.30 (2.5) N50 (ND)
δΔGC15-NS (kcal/mol)d 0.18 1.4
Trp ﬂuorescencee
μM μM
RTA3-F9W 15 16
RTA3-F9W,C15S 31 148
δΔGC15-NS (kcal/mol) 0.42 1.3
a Peptide concentration that induced half-maximal CF dye release from 100 nm LUV
(65 μM total lipid).
b Peptide concentration that induced half-maximal ﬂuorescence shift in FPE-doped
vesicles.
c Value of n (peptide concentration power dependence) in the sigmoidal ﬁt of dye
release data to Eq. (4).
d Free energy contribution to membrane binding arising from the C15 to S
substitution.
e Lipid concentration (as 100 nm LUV) that induced 50% peptide binding; peptide
concentration was 2 μM.
Fig. 5. Peptide-induced permeabilization of the outer membrane of E. coli 345-2 to
nitroceﬁn. Data inMg2+-freemedium is shown; see Table 3 for permeabilization data in
the presence of 0.4 mM Mg2+. Peptides are (circles) RTA3, (squares) RTA3-C15L,
(triangles) RTA3-C15S, and (diamonds) polymixin E.
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inactive as a permeabilizer of pure PC bilayers, a consequence of the
inability of the peptide to bind to a membrane lacking a negative
surface charge. The slightly enhanced hydrophobicity of RTA3-C15L
compared to RTA3 is probably the reason for the retention of weak
permeabilizing activity in 100% PC bilayers (Fig. 2B).
3.3. Membrane binding of RTA3 peptide variants
Peptide-inducedmembrane permeabilization follows binding to the
membrane surface. Toassess the relationship betweenpermeabilization
and binding we measured binding of RTA3 and RTA3-C15S to vesicles
composed of PC/PG (50:50) and PC/PG (80:20) using FPE (0.5%) as a
binding-responsive ﬂuorescent probe. In addition, wemeasured vesicle
bindingof variants containing a Phe9 toTrp9 substitution tomonitor the
blue shift in the Trp ﬂuorescence emission spectrum that occurs upon
membranebinding [1]. Like thePhe4 toTrp4variants of RTA3previously
reported [1], the Phe9 to Trp9 variants have essentially the same
antimicrobial activity as the unsubstituted peptides. Each of these
analyses allows a quantitation of the change in binding free energy
(Table 2) upon substituting Cys15with Ser that can be used to interpret
the amino acid speciﬁc contribution to binding in terms of published
free energy scales (see Discussion).
Figs. 3A and B show binding of RTA3 and RTA3-C15S to FPE-doped
vesicles [PC/PG (50:50) and PC/PG (80:20)] and RTA3-F9W and
RTA3-F9W,C15S binding to undoped vesicles, respectively. In both
cases, the C15S variants bound slightly more weakly to PC/PG bilayers
containing 50% PG (by 1.3- to 2-fold) and the C15S variants bound
much more weakly (by 9.3- to 12-fold) to bilayers containing only
20% PG. Since the peptides exhibit hyperbolic binding (Fig. 3),
whereas dye release under our experimental protocol has a sigmoidal
dependence on peptide concentration (Fig. 2; Table 2) [1], a small
reduction in binding free energy to bilayers containing a reduced
negative charge resulting from the Cys-15 to Ser substitution,
translates into a large reduction in membrane disruption. RTA3 and
RTA3-C15S have very similar CD spectra when bound to PC/PG
(50:50) vesicles, indicating that the C15S substitution does not induce
signiﬁcant helix unwinding in the C15S variant when bound at the
surface of the membrane with high negatively charged lipid content
(Fig. 4).
These observations support the conclusions that the main effect of
the serine substitution in RTA3-C15S in reducing antimicrobial
activity, is via reduction of membrane binding, and that effects on
target cell membranes are likely key elements in the antimicrobial
activity of RTA3. We explore the latter conclusion below.3.4. Membrane-selective effects of RTA3 peptides
To assess the relationships between membrane binding in model
bilayers, membrane perturbation in bacterial membranes, and
antimicrobial activity, we measured peptide-induced perturbation
of inner (IM) and outer (OM) membranes of the Gram-negative
bacterium E. coli. We compared the data from the RTA3 peptide
variants with the clinically used antibiotic polymyxin E (colistin), a
membrane active cyclic cationic peptide [20]. Polymixin E is known to
act on the outer membrane of Gram-negative bacteria, interacting
with lipopolysaccharide and increasing outer membrane permeability
by displacing membrane-stabilizing divalent cations [20]. We tested
the ability of RTA3 peptides and polymixin E to permeabilize the outer
membrane (OM) and inner membrane (IM) of E. coli strains, E coli
345-2 and E coli 122, that overexpress perplasmic β-lactamase or
cytoplasmic β-galactosidase, respectively. OM permeabilization pro-
motes access of β-lactamase to the reporter substrate nitroceﬁn, and
IM permeabilization promotes access of β-galactosidase to its reporter
substrate ortho-nitrophenyl-β-galactoside (ONPG). In order to
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activity, we also measured cell killing of the appropriate E. coli strains
(E. coli 345-2 and E. coli 122) under the same conditions used for
membrane permeability (but excluding reporter substrates).
These data are summarized in Figs. 5–7 and Table 3. We measured
peptide-induced membrane-selective permeabilization in the ab-
sence and presence of 0.4 mMMgCl2 since divalent cations are known
to stabilize Gram-negative bacterial membranes and are included in
cation-adjusted Muller–Hinton media used to determine MICs. All of
the peptides with high antimicrobial activities were effective in
permeabilizing the outer membrane, allowing access of nitroceﬁn to
periplasmic β-lactamase. RTA3-C15S, however, showed negligible OM
permeabilizing activity (Fig. 5). Both RTA3 and polymixin E retain
very high permeabilizing activity in the presence of 0.4 mM Mg2+
(Table 3), indicating an ability to compete with this divalent cation for
binding sites on the outer membrane. The permeabilizing activity of
RTA3-C15L was reduced somewhat by Mg2+, and this may be related
to the reduced activity of this analogue in cation-adjusted Muller–
Hinton media compared to RTA3 (Table 1). The low OM-permeabiliz-
ing activity of RTA3-C15S was abolished in the presence of Mg2+.
RTA3 and RTA3-C15L effectively permeabilize the innermembrane
of E coli 122 allowing access of ONPG to cytoplasmic β-galactosidase
(Fig. 6). The inactive RTA3-C15S is very poorly effective as an IM
permeabilizer, as is polymixin E, consistent with previous observa-
tions using polymixins (polymixin B) [21]. The permeabilizing
activities of both RTA3 and RTA3-C15L are reduced somewhat by
0.4 mM Mg2+. It is notable that the membrane permeabilizing
activities of RTA3 and RTA3-C15L on the IM and OM in Mg2+-
containing media are comparable to the MICs of these peptide against
E. coli strains measured under standard conditions in cation-adjusted
Muller–Hinton media (Table 1).
When membrane-selective permeabilization is compared with
bacterial cell killing under equivalent conditions (Fig. 7), the
relationships between membrane permeabilization and cell killing
are more apparent. RTA3 effectively kills E. coli 345-2 at concentra-
tions well below those yielding signiﬁcant OM permeabilization to
nitroceﬁn, whereas concentrations that kill E. coli 122 are closer to
(but still lower than) those permeabilizing the IM (Fig. 7A). On the
other hand, polymixin E kills E. coli 122 at concentrations well below
those required for IM permeabilization that allows ONPG access to the
cytoplasm. As expected, the poor membrane-permeabilizing activity
of RTA3-C15S is matched by very low bacterial cell killing activity
unless peptide concentrations are considerably enhanced (Fig. 7C;
note the expanded concentration scale on this panel). In this case, cell
killing and membrane permeabilization to IM and OM markerFig. 6. Peptide-induced permeabilization of the inner membrane of E. coli 122 to ONPG.
Data in Mg2+-free medium is shown; see Table 3 for permeabilization data in the
presence of 0.4 mM Mg2+. Peptides are (circles) RTA3, (squares) RTA3-C15L,
(triangles) RTA3-C15S, and (diamonds) polymixin E.
Fig. 7. Peptide-induced permeabilization of E coli membranes and associated bacterial
killing. Data are for RTA3 (A), polymixin E (B), and RTA3-C15S (C; note the expanded
concentration scale). In each case, circles denote membrane permeabilization allowing
access of marker substrates, and triangles denote bacterial killing as follows: (●) outer
membrane permeabilization of E. coli 345-2; (o) innermembrane permeabilization of E.
coli 122; (▲) killing of E. coli 345-2; (Δ) killing of E. coli 122.substrates occur at equivalent peptide concentrations, indicating a
closer association of membrane permeabilization (especially IM
permeabilization) and bacterial killing.Table 3
Peptide permeabilization of E. coli Outer and Inner membrane.
OM IM
−Mg2+ +Mg2+ −Mg2+ +Mg2
μM μM μM μM
RTA3 3a 3.5 0.8 2.5
RTA3-C15S N70 NAb 18 N100
RTA3-C15L 6 11 1 6
Polymixin E 2 1.8 N40 N100
a Values are the peptide concentration resulting in half-maximal translocated
substrate turnover.
b No activity (no measurable permeabilization at 50 μM peptide concentration).
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The data presented indicate that the Cys-15 residue in RTA3 is not
absolutely required for high antimicrobial activity, since the cysteine
can be replaced with a leucine with the retention of much of the
activity of the native peptide. We have employed these peptides, as
well as an RTA3-C15S variant, to address mechanistic aspects of the
anti-Gram-negative activity of RTA3.
4.1. Surface charge effects on RTA3-C15S membrane binding
Comparison of RTA3 and RTA3-C15S highlights the interplay of
amphipathicity and electrostatics that underlies the combination of
high antimicrobial activity and strong prokaryotic-selective toxicity
required for therapeutic potential in positively charged helical
antimicrobial peptides. While RTA3-C15S has antimicrobial activity
reduced by around 60-fold relative to RTA3 (Table 1), RTA3-C15S is
only 2- to 3-fold less effective than RTA3 in disrupting membranes
composed of equimolar PC and PG (Fig. 2). However, if these peptides
are tested for their abilities to permeabilize vesicles composed of
lipids having negative charge density closer to that of the inner
membrane (IM) of Gram-negative bacteria (i.e., PE/PG/CL, 80:10:15
or PC/PG, 80:20; Figs. 1 and 2), the permeabilizing activity of RTA3-
C15S is greatly reduced (up to 100-fold) while RTA3 and RTA3-C15L
retain very high activity. Both the absolute and relative effectiveness
in killing Gram-negative bacteria (E. coli and P. aeruginosa) are
broadly reproduced in PC bilayers containing 20% PG.
The origin of the large selective loss of membrane-permeabilizing
activity inRTA3-C15S that results from reducing the PG content ofmixed
PC/PG bilayers from 50% to 20% can be assessed by comparison of lipid
bindingafﬁnities. The ratios of binding constants of RTA3andRTA3-C15S
in 50% PC/PG [1.4:1 (from FPE ﬂuorescence) and 2.0:1 (Trp ﬂuores-
cence)] and in 80% PC/20% PG [9.3:1 (FPE) and 12:1(Trp)] are similar to
those expected if the context of the C15→S substitution in 50% PG
bilayers is the membrane interfacial region [22], whereas the context of
the same substitution in 20% PG is a somewhat deeper region of theFig. 8. Schematic illustration of the effect of the RTA3-C15S mutation on interfacial membran
fold; δΔG∼0.2–0.4 kcal/mol) reduction in membrane binding for RTA3-C15S (right) comp
interfacial localization of the C15 residue, since the free energy “cost” of a Cys-Ser replaceme
White [22]. A more dramatic loss of membrane partitioning is expected for this mutation if th
In this case, the free energy “cost” is expected to be in the range of 1–4.5 kcal/mol based o
towards the nonpolar regions of the membrane, consistent with the reduced binding consta
bilayers (Fig. 3; Table 2). Hydrophobic amino acids are colored yellow; polar uncharged rebilayer where the environment is more hydrophobic [23,24]. This is
illustrated in the schematic of Fig. 8 which shows space-ﬁllingmodels of
RTA3 and RTA3-C15S in a helical conformation ([1]; Fig. 4), at the
membrane interface. Interfacially localized helical peptides lie at a
shallow depth in the bilayer [25], and this is likely to be promoted by
high negative charge density for positively charged peptides. The free
energy cost of replacing an interfacially located cysteine residue with a
serine is small (∼0.37 kcal/mol), according to the free energy scale of
Wimley and White for interfacial partitioning in POPC [22], similar to
that found for the RTA3-C15S substitution in PC/PG (50:50) (∼0.2–
0.4 kcal/mol; Table 2). In a membrane with reduced negative charge
density, the reduction in the electrostatic contribution to bindingmay be
compensated in RTA3 by sinking of the peptide slightly deeper into the
bilayer (or tilting of thehelix axiswith respect to themembrane surface)
such that the bulky hydrophobic side chains that line the hydrophobic
face of the helix near the C-terminus make productive interactions with
the acyl chain region of the bilayer (Fig. 8). In this context, replacing a
cysteine side chain with a serine side chain can “cost” from between
1 kcal/mol to 4.68 kcal/mol, based, respectively, on the preference of
amino acid side chains to fall within the transmembrane regions of
membrane-spanning peptides [24] and the transfer of amino acid side
chains from water to cyclohexane [23]. Since the water–cyclohexane
partitioning scale for amino acid side chains is an overextrememeasure
of the hydrophobicity of a membrane environment in the context of a
surface-lying amphipathic helical peptide, an intermediate free energy
cost, equivalent to a reduced surface partitioning of RTA3-C15S
compared to RTA3 near 9.3- to 12-fold (δΔG∼1.3–1.4 kcal/mol;
Table 2), is consistent with a small movement of the C-terminal region
of the peptide towards the less polar regions of the bilayer.We note that
a strict quantitative interpretation of this data in terms of the interfacial
partitioning free energy scale requires that the difference in interfacial
partition free energies (Cys→Ser) is the same in unsaturated PC
membranes containing 50% or 20% PG (this study), as in POPC [22].
While themembrane compositiondependenceof interfacialpartitioning
free energies has not yet been systematically explored, this assumption
is likely to be most reliable for amino acid substitutions involvinge binding according to the depth of membrane surface penetration. The small (1.3- to 2-
ared to RTA3 (left) in PC/PG (50:50) bilayers (Fig. 3; Table 2) is consistent with an
nt is around 0.36 kcal/mol according to the interfacial partitioning scale of Wimley and
e C-terminal region lies somewhat deeper in the bilayer in a PC/PG (80:20) membrane.
n the Hessa [24] and Wolfenden [23] scales for partitioning of amino acid side chains
nt (9.5- to 12-fold; δΔG∼1.3–1.4 kcal/mol) of RTA3-C15S compared to RTA3 in 20% PG
sidues are green; Lys, Arg residues are blue.
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very small effect (1.5- to 2-fold reduction) on interfacial partitioning of
RTA3 in PC/PG (50:50), and amuch larger effect (9.3- to 12-fold) in PC/
PG (80:20) is independent of any assumptions in the use of free energy
scales for analyzing membrane binding.
The membrane perturbations induced by amphipathic peptides in
vesicles often show sigmoidal concentration dependence, and as
indicated by peptide cross-linking experiments [18,26], this can
indicate cooperativity in the peptide-induced membrane disruption
that underlies efﬂux of vesicle-entrapped molecules. Without simi-
larly establishing cooperativity in the mechanism of peptide-induced
membrane permeabilization, cooperativity (e.g., pore formation
involving self-association of membrane-bound peptide) cannot be
assumed from a sigmoidal concentration dependence, especially
when using an experimental protocol in which the kinetics of dye
release is sampled at a single time point. However, a combination of
hyperbolic (noncooperative) membrane binding and a sigmoidal
peptide concentration dependence for dye release underlies the
observation that relatively small (∼10-fold) reductions in binding
afﬁnities can result in much larger reductions (∼50-100-fold) in
membrane perturbation. These subtle differences in membrane
binding to membranes with different negative charge densities may
underlie some of the variation in peptide antimicrobial activities
against different bacterial species [2–7,27]. Detailed analysis of the
thermodynamics of membrane binding may allow the relationships
between peptide sequence variation and organism- and strain-
speciﬁc antimicrobial activities to be understood in more detail.
4.2. Membrane-speciﬁc effects of RTA3 peptides on bacterial cells
The general relationship between antimicrobial activity against
Gram-negative bacteria and the permeabilization of negatively
charged membranes having reduced negative charge density (Figs. 1
and 2; Tables 1 and 2; see also [1]) supports a signiﬁcant role for
membrane activity in the antimicrobial mechanism(s) of these
peptides. The effects of the peptides in permeabilizing E. coli inner
and outer membranes highlight differences in the properties of RTA3
peptides and polymixin E (consistent with the observation of RTA3–
polymixin E synergies).1 Both polymixin E and active RTA3 variants
(RTA3; RTA3-C15L) strongly permeabilize the OM to nitroceﬁn
whereas only the RTA3 peptides permeabilize the IM to ONPG.
Polymixin E is known to bind to lipopolysaccharide on the OM,
permeabilizing the OM and promoting self-uptake of the peptide into
the periplasm [20]. Direct comparison of bacterial cell killing under
conditions equivalent to the permeabilization assays indicates that all
of the active peptides kill E. coli strains at concentrations below those
required for outer or inner membrane permeabilization to the marker
substrates nitroceﬁn or ONPG. This is particularly marked for
polymixin E, where cell killing and inner membrane permeabilization
to ONPG are completely dissociated (Fig. 7B). Previous studies dem-
onstrate that polymixin B can permeabilize the IM to ions at peptide
concentrations that are closer to the MICs [21], and the similarities
between polymixins B and E suggest that the killing mechanism of
polymixin E may involve effects on the IM [28]. However, the obser-
vations demonstrate that polymixin E does not induce marked IM
permeability to molecules of the size of ONPG in the manner of the
active RTA3 peptides.
The IM permeabilization to ONPG by active RTA3 peptides occurs
at concentrations slightly higher than those required for cell killing; in
the case of the poorly active RTA3-C15S, cell killing is induced only at
concentrations that promote permeabilization of the IM. These
observations are consistent with the conclusion that IM perturbation
by active RTA3 peptides at concentrations slightly below those
required to allow permeabilization to ONPG may be associated with
target cell death either by direct effects on membrane functions [29],
permeabilization to molecules (water and ions) smaller than ONPG(MW 301), or following translocation of peptide into the bacterial
cytoplasm to act on intracellular targets [30,31].
The results presented support the conclusion that bacterial cell
killing by RTA3 peptides derived from a commensal organism is
associated with bacterial membrane perturbation and that these
properties can be understood in relation to the thermodynamics of
membrane binding to lipids in which the negative surface charge is
matched to that of the target cell membrane; for RTA3 peptides,
membranes composed of unsaturated 20% PG/80% PC lipids provide
a good analogue for peptide activity against Gram-negative bacteria
E. coli and P. aeruginosa. Subtle changes in amino acid composition
that have small effects on membrane binding can have large effects
on membrane perturbation because of the apparent cooperativity in
membrane perturbation, and these effects seem to be reﬂected in
the relative activities against target bacteria. An extended analysis
of the membrane binding of substitution analogues of peptides of
this class is likely to be useful in further testing and reﬁning free
energy scales for amino acid contributions to membrane partition-
ing of polypeptides, especially in narrowing the wide range of free
energies associated with deeper insertion of amino acids into
membranes [23,24,32] that likely relates to structural and sequence
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